CLINICAL_TRIALS
trial_result
· 2025-05-09
Clinical Trial Update: Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness [Phase 2]
Summary
Phase 2 trial of tradipitant for motion sickness has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanda Pharmaceuticals | Conditions: Motion Sickness | Phase 2 | Status: COMPLETED | Results posted: 2025-05-09